<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="urn:hl7-org:v3" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="1b2e0f61-8590-77db-e063-6294a90a72c9"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>NyamycÂ®
 <br/>
(Nystatin Topical Powder, USP)
</title>
   <effectiveTime value="20240618"/>
   <setId root="01b44f91-9b68-464a-9693-b5d3e793bf3c"/>
   <versionNumber value="11"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id root="1.3.6.1.4.1.519.1" extension="047251004"/>
            <name>Upsher-Smith Laboratories, LLC</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id root="1.3.6.1.4.1.519.1" extension="079111820"/>
                        <name>Upsher-Smith Laboratories, LLC</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C43360" displayName="manufacture" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0832-0465" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84732" displayName="label" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0832-0465" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" displayName="pack" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0832-0465" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="1b2f1dfd-8122-419e-e063-6394a90a0afe"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20240618"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0832-0465" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Nyamyc</name>
                        <formCode code="C42972" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="POWDER"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Nystatin</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="7SEV7J4R1U" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>TALC</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="[USP'U]" value="100000"/>
                              <denominator unit="g" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="BDF1O1C72E" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>NYSTATIN</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="BDF1O1C72E" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>NYSTATIN</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="15" unit="g"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43173" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, PLASTIC"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0832-0465-15" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20050503"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator value="30" unit="g"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43173" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, PLASTIC"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0832-0465-30" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20050503"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator value="60" unit="g"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43173" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, PLASTIC"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0832-0465-60" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20120309"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA065183" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20050503"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38304" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TOPICAL"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section>
               <id root="1b2e0f61-8591-77db-e063-6294a90a72c9"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">100,000 units per gram 
   <br/>  Rx only
  </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">FOR TOPICAL USE ONLY â¢ NOT FOR OPHTHALMIC USE</content>
                  </paragraph>
               </text>
               <effectiveTime value="20200618"/>
            </section>
         </component>
         <component>
            <section>
               <id root="1b2e0f61-8592-77db-e063-6294a90a72c9"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION</title>
               <text>
                  <paragraph>Nystatin is a polyene antifungal antibiotic obtained from
 
  <content styleCode="italics">Streptomyces nursei.</content>
                  </paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="MM1"/>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">NyamycÂ®</content>(Nystatin Topical Powder, USP) is for dermatologic use.

 </paragraph>
                  <paragraph>
                     <content styleCode="bold">NyamycÂ®</content>(Nystatin Topical Powder, USP) contains 100,000 USP nystatin units per gram dispersed in talc.

 </paragraph>
               </text>
               <effectiveTime value="20200618"/>
               <component>
                  <observationMedia ID="MM1">
                     <text>Chemical Structure</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="nyamyc-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="1b2e0f61-8593-77db-e063-6294a90a72c9"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY</title>
               <effectiveTime value="20200618"/>
               <component>
                  <section>
                     <id root="1b2e0f61-8594-77db-e063-6294a90a72c9"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                     <title>Pharmacokinetics</title>
                     <text>
                        <paragraph>Nystatin is not absorbed from intact skin or mucous membrane.</paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="1b2e0f61-8595-77db-e063-6294a90a72c9"/>
                     <code code="49489-8" codeSystem="2.16.840.1.113883.6.1" displayName="MICROBIOLOGY SECTION"/>
                     <title>Microbiology</title>
                     <text>
                        <paragraph>Nystatin is an antibiotic which is both fungistatic and fungicidal
 
  <content styleCode="italics">in vitro</content>against a wide variety of yeasts and yeast-like fungi, including
 
  <content styleCode="italics">Candida albicans, C. parapsilosis, C. tropicalis, C. guilliermondi, C. pseudotropicalis, C. krusei, Torulopsis glabrata, Tricophyton rubrum, T. mentagrophytes.</content>
                        </paragraph>
                        <paragraph>Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing levels of nystatin,
 
  <content styleCode="italics">Candida albicans</content>does not develop resistance to nystatin. Generally, resistance to nystatin does not develop during therapy. However, other species of
 
  <content styleCode="italics">Candida (C. tropicalis, C. guilliermondi, C. krusei, and C. stellatoides)</content>become quite resistant on treatment with nystatin and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed.

 </paragraph>
                        <paragraph>Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.</paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="1b2e0f61-8596-77db-e063-6294a90a72c9"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">NyamycÂ®</content>(Nystatin Topical Powder, USP) is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by
 
  <content styleCode="italics">Candida albicans</content>and other susceptible
 
  <content styleCode="italics">Candida</content>species.

 </paragraph>
                  <paragraph>
                     <content styleCode="bold">NyamycÂ® (Nystatin Topical Powder, USP) is not indicated for systemic, oral, intravaginal or ophthalmic use.</content>
                  </paragraph>
               </text>
               <effectiveTime value="20200618"/>
            </section>
         </component>
         <component>
            <section>
               <id root="1b2e0f61-8597-77db-e063-6294a90a72c9"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">NyamycÂ®</content>(Nystatin Topical Powder, USP) is contraindicated in patients with a history of hypersensitivity to
 
  <content styleCode="bold">any</content>of its components.

 </paragraph>
               </text>
               <effectiveTime value="20200618"/>
            </section>
         </component>
         <component>
            <section>
               <id root="1b2e0f61-8598-77db-e063-6294a90a72c9"/>
               <code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS</title>
               <effectiveTime value="20200618"/>
               <component>
                  <section ID="general">
                     <id root="1b2e0f61-8599-77db-e063-6294a90a72c9"/>
                     <code code="34072-9" codeSystem="2.16.840.1.113883.6.1" displayName="GENERAL PRECAUTIONS SECTION"/>
                     <title>General</title>
                     <text>
                        <paragraph>
                           <content styleCode="bold">NyamycÂ® (Nystatin Topical Powder, USP) should not be used for the treatment of systemic, oral, intravaginal or ophthalmic infections.</content>
                        </paragraph>
                        <paragraph>If irritation or sensitization develops, treatment should be discontinued and appropriate measures taken as indicated. It is recommended that KOH smears, cultures, or other diagnostic methods be used to confirm the diagnosis of cutaneous or mucocutaneous candidiasis and to rule out infection caused by other pathogens.</paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="1b2e0f61-859a-77db-e063-6294a90a72c9"/>
                     <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
                     <title>INFORMATION FOR THE PATIENT</title>
                     <text>
                        <paragraph>Patients using this medication should receive the following information and instructions:</paragraph>
                        <list listType="ordered" styleCode="Arabic">
                           <item>The patient should be instructed to use this medication as directed (including the replacement of missed doses). This medication is not for any disorder other than that for which it is prescribed.</item>
                           <item>Even if symptomatic relief occurs within the first few days of treatment, the patient should be advised not to interrupt or discontinue therapy until the prescribed course of treatment is completed.</item>
                           <item>If symptoms of irritation develop, the patient should be advised to notify the physician promptly.</item>
                        </list>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="1b2e0f61-859b-77db-e063-6294a90a72c9"/>
                     <code code="34075-2" codeSystem="2.16.840.1.113883.6.1" displayName="LABORATORY TESTS SECTION"/>
                     <title>Laboratory Tests</title>
                     <text>
                        <paragraph>If there is a lack of therapeutic response, KOH smears, cultures, or other diagnostic methods should be repeated.</paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="1b2e0f61-859c-77db-e063-6294a90a72c9"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>Carcinogenesis, Mutagenesis, Impairment of Fertility</title>
                     <text>
                        <paragraph>No long-term animal studies have been performed to evaluate the carcinogenic potential of nystatin. No studies have been performed to determine the mutagenicity of nystatin or its effects on male or female fertility.</paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="1b2e0f61-859d-77db-e063-6294a90a72c9"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>Pregnancy</title>
                     <effectiveTime value="20200618"/>
                     <component>
                        <section>
                           <id root="1b2e0f61-859e-77db-e063-6294a90a72c9"/>
                           <code code="34077-8" codeSystem="2.16.840.1.113883.6.1" displayName="TERATOGENIC EFFECTS SECTION"/>
                           <title>Teratogenic Effects</title>
                           <text>
                              <paragraph>Animal reproduction studies have not been conducted with any nystatin topical preparation. It also is not known whether theses preparations can cause fetal harm when used by a pregnant woman or can affect reproductive capacity.
 
  <content styleCode="bold">NyamycÂ®</content>(Nystatin Topical Powder, USP) should be prescribed for a pregnant woman only if the potential benefit to the mother outweighs the potential risk to the fetus.

 </paragraph>
                           </text>
                           <effectiveTime value="20200618"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="1b2e0f61-859f-77db-e063-6294a90a72c9"/>
                     <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION"/>
                     <title>Nursing Mothers</title>
                     <text>
                        <paragraph>It is not known whether nystatin is excreted in human milk. Caution should be exercised when nystatin is prescribed for a nursing woman.</paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="1b2e0f61-85a0-77db-e063-6294a90a72c9"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>Pediatric Use</title>
                     <text>
                        <paragraph>Safety and effectiveness have been established in the pediatric population from birth to 16 years.
 
  <content styleCode="italics">[see</content>
                           <content styleCode="bold">
                              <content styleCode="italics">
                                 <linkHtml href="#dosage">DOSAGE AND ADMINISTRATION</linkHtml>
                              </content>
                           </content>
                           <content styleCode="italics">].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
               <component>
                  <section>
                     <id root="1b2e0f61-85a1-77db-e063-6294a90a72c9"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>Geriatric Use</title>
                     <text>
                        <paragraph>Clinical studies with nystatin topical powder did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.</paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="1b2e0f61-85a2-77db-e063-6294a90a72c9"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS</title>
               <text>
                  <paragraph>The frequency of adverse events reported in patients using nystatin topical preparations is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application.
 
  <content styleCode="italics">[see</content>
                     <content styleCode="bold">
                        <content styleCode="italics">
                           <linkHtml href="#general">PRECAUTIONS: General</linkHtml>
                        </content>
                     </content>
                     <content styleCode="italics">].</content>
                  </paragraph>
               </text>
               <effectiveTime value="20200618"/>
            </section>
         </component>
         <component>
            <section ID="dosage">
               <id root="1b2e0f61-85a3-77db-e063-6294a90a72c9"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph>Very moist lesions are best treated with the topical dusting powder.</paragraph>
               </text>
               <effectiveTime value="20200618"/>
               <component>
                  <section>
                     <id root="1b2e0f61-85a4-77db-e063-6294a90a72c9"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Adults and Pediatric Patients (Neonates and Older)</title>
                     <text>
                        <paragraph>Apply to candidal lesions two or three times daily until healing is complete. For fungal infection of the feet caused by
 
  <content styleCode="italics">Candida</content>species, the powder should be dusted on the feet, as well as, in all foot wear.

 </paragraph>
                     </text>
                     <effectiveTime value="20200618"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section>
               <id root="1b2e0f61-85a5-77db-e063-6294a90a72c9"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">NyamycÂ® (Nystatin Topical Powder, USP)</content>100,000 units nystatin per gram is available as follow:

 </paragraph>
                  <table width="60%" styleCode="Noautorules">
                     <col width="30%" align="left" valign="top"/>
                     <col width="70%" align="left" valign="top"/>
                     <tbody>
                        <tr>
                           <td>Â Â Â Â Bottles of 15 g</td>
                           <td>(NDC 0832-0465-15)</td>
                        </tr>
                        <tr>
                           <td>Â Â Â Â Bottles of 30 g</td>
                           <td>(NDC 0832-0465-30)</td>
                        </tr>
                        <tr>
                           <td>Â Â Â Â Bottles of 60 g</td>
                           <td>(NDC 0832-0465-60)</td>
                        </tr>
                     </tbody>
                  </table>
               </text>
               <effectiveTime value="20200618"/>
               <component>
                  <section>
                     <id root="1b2e0f61-85a6-77db-e063-6294a90a72c9"/>
                     <code code="44425-7" codeSystem="2.16.840.1.113883.6.1" displayName="STORAGE AND HANDLING SECTION"/>
                     <title>STORAGE</title>
                     <effectiveTime value="20200618"/>
                     <component>
                        <section>
                           <id root="1b2e0f61-85a7-77db-e063-6294a90a72c9"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <title>NyamycÂ® (Nystatin Topical Powder, USP)</title>
                           <text>
                              <paragraph>Store at 20Â° to 25Â°C (68Â° to 77Â°F); excursions permitted to 15Â° to 30Â°C (59Â° to 86Â°F) [See USP Controlled Room Temperature]. Avoid excessive heat (40Â°C/104Â°F). Keep tightly closed. Keep out of reach of children.</paragraph>
                              <paragraph>Nyamyc is a registered trademark of Upsher-Smith Laboratories, LLC.</paragraph>
                           </text>
                           <effectiveTime value="20200618"/>
                        </section>
                     </component>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="id_link_1b2e0f61-85ab-77db-e063-6294a90a72c9">
               <id root="1b2e0f61-85aa-77db-e063-6294a90a72c9"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <text>
                  <paragraph>Manufactured by
  <br/>
                     <content styleCode="bold">UPSHER-SMITH LABORATORIES, LLC</content>
                     <br/>
Maple Grove, MN 55369
 </paragraph>
                  <paragraph>Revised: 6/2024</paragraph>
               </text>
               <effectiveTime value="20200618"/>
            </section>
         </component>
         <component>
            <section ID="id_link_1b2e2115-30ea-c480-e063-6394a90a3369">
               <id root="1b2f6473-6d25-066f-e063-6394a90a4cb5"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 15 gram Bottle Carton</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">NDC 0832-0465-15
   <br/>
Nyamyc 
   <sup>Â®</sup>
                        <br/>
Nystatin Topical Powder, USP 
  </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">100,000 USP
   <br/>
units per gram
  </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">FOR TOPICAL USE ONLY.
   <br/>
NOT FOR OPHTHALMIC USE.
  </content>
                  </paragraph>
                  <paragraph>NET WT. 15 grams
  <br/>
                     <content styleCode="bold">Rx only</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">UPSHER-SMITH</content>
                  </paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="img_1b2f615f-a8ff-8c44-e063-6294a90a5534"/>
                  </paragraph>
                  <paragraph/>
                  <paragraph/>
                  <paragraph/>
                  <paragraph/>
                  <paragraph/>
                  <paragraph/>
                  <paragraph/>
                  <paragraph/>
                  <paragraph/>
               </text>
               <effectiveTime value="20200618"/>
               <component>
                  <observationMedia ID="img_1b2f615f-a8ff-8c44-e063-6294a90a5534">
                     <text>label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="nyamyc-02.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>